AtaiBeckley (ATAI) Acquisitions (2021)

AtaiBeckley (ATAI) reported Acquisitions of $37000.0 for Q2 2021, up 270.0% sequentially from $10000.0 in Q1 2021.

AtaiBeckley (ATAI) Acquisitions (2021) Analysis & Trends

AtaiBeckley (ATAI) has 1 years of Acquisitions data on file, last reported at $37000.0 in Q2 2021.

For the quarter ending Q2 2021, Acquisitions changed N/A year-over-year to $37000.0; the trailing twelve-month figure through Mar 2022 stood at $37000.0 (changed N/A YoY), and the FY2024 full-year result was $359000.0, changed N/A from the prior year.
Acquisitions improved to $37000.0 in Q2 2021, from $10000.0 in the prior quarter.
In the past five years, Acquisitions ranged from a high of $37000.0 in Q2 2021 to a low of $10000.0 in Q1 2021.

Peer Comparison

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Acquisitions (Qtr)
1	Oculis Holding AG	68,785.72 Bn	68,785.72 Bn	-	-
2	Nanobiotix	1,895.57 Bn	1,895.51 Bn	-	-
3	BeOne Medicines	471.35 Bn	466.56 Bn	1.35 Bn	-
4	NuCana	279.75 Bn	279.75 Bn	-	-
5	Vertex Pharmaceuticals	120.24 Bn	113.00 Bn	2.59 Bn	-
6	Regeneron Pharmaceuticals	67.80 Bn	59.04 Bn	3.31 Bn	-
7	Belite Bio	62.51 Bn	62.51 Bn	-	-
8	Argenx Se	57.38 Bn	57.38 Bn	1.41 Bn	-
9	Revolution Medicines	37.78 Bn	37.78 Bn	-	-
10	AtaiBeckley	2.56 Bn	2.56 Bn	-	-

Historic Data

Download Data

Date	Value
Jun 30, 2021	37,000.00
Mar 31, 2021	10,000.00